🎉 As we complete the first 20 months of the PREDICTFTD project, it is a great moment to look back at where it all began. These photos take us back to our kick-off meeting at Erasmus MC in Rotterdam.
PREDICTFTD
@predictftd.bsky.social
Accelerating the Validation of Predictive Liquid Biomarkers for Frontotemporal Dementia Diagnosis and Subclassification
🔍 Project Spotlight: DORIAN GRAY We are pleased to introduce DORIAN GRAY, a Horizon Europe project investigating the link between cardiovascular disease and mild cognitive impairment in the ageing population. 🎥 Learn more: www.youtube.com/watch?v=ghLa...
The DORIAN GRAY project: Empowering Healthy Aging with AI and Innovation
YouTube video by Dorian Gray EU Project
youtube.com
A new article highlights an exciting step forward: a simple olfactory swab that has the potential to support earlier FTD diagnosis and improve patient care. The article features the pioneering work of Prof. Gianluigi Zanusso.📃 Read the full article here: www.predictftd.eu/news/a-simpl...
A Simple Olfactory Swab for Earlier Frontotemporal Dementia Diagnosis | PREDICTFTD
predictftd.eu
📢 We are glad to share that PREDICTFTD is featured on CORDIS, the European Commission’s platform for EU-funded research and innovation projects. 🔗 Learn more about the project: cordis.europa.eu/project/id/1...
Accelerating the Validation of Predictive Liquid Biomarkers for Frontotemporal Dementia Diagnosis and Subclassification | PREDICTFTD | Project | Fact Sheet | HORIZON | CORDIS | European Commission
Frontotemporal dementia (FTD) has a debilitating effect on patients and their caregivers and leads to substantial economic costs. 15-30% of patients have familial FTD caused by known pathogenetic muta...
cordis.europa.eu
📢 @ohenews.bsky.social at the CEPR - Centre for Economic Policy Research Conference on the Economics of Longevity and Ageing. We are pleased to share that @Mireia Jofre-Bonet has been invited to participate in a panel discussion on the economic impacts of dementia.
A great day at Dementia Day 2026 – Building Bridges Together at Alzheimercentrum @erasmusmc.bsky.social! Congratulations to our partner Laura Dias, who received the poster prize for her work on "Modeling of White Matter Degeneration in Genetic Frontotemporal Dementia." 🏆
Our project partner, Alzheimer Europe, has just published the newest edition of Dementia in Europe magazine! Explore the latest stories and insights on dementia research, policy, care, and lived experience from across Europe.
Alzheimer Europe is pleased to introduce issue 51 of the Dementia in Europe magazine! There has been much valuable work taking place across Europe in the domains of policy, research, culture and care, and we are delighted to showcase these in our magazine. #DementiaInEurope bit.ly/DementiaInEu...
Congratulations to Kuopio Neuroscience on its 50th anniversary! 🎉 Great to see PREDICTFTD partners taking part in the FinFTD Minisymposium in Kuopio, Finland, discussing FTD biomarkers, epidemiology, clinical phenotypes, and the importance of international collaboration.
📃 We’re excited to share our new PREDICTFTD flyer highlighting the potential of nasal (olfactory) swabs in frontotemporal dementia research. www.predictftd.eu/disseminatio...
Prof. Harro Seelaar (@erasmusmc.bsky.social), PREDICTFTD Coordinator, joined the latest @alzheimereurope.bsky.social Academy session, “Not all dementias are Alzheimer’s disease,” to share a clinician’s perspective on frontotemporal dementia (FTD). www.alzheimer-europe.org/news/alzheim...
Alzheimer Europe hosts a session of its Alzheimer’s Association Academy entitled "Not all dementias are Alzheimer’s disease”
On 26 May, Alzheimer Europe held a session of its online workshop series the Alzheimer's Association Academy, entitled "Not all dementias are Alzheime
alzheimer-europe.org
📢 On International Clinical Trials Day, we recognise the vital contribution of people who participate in clinical research and help drive progress in dementia care.
💡 Did you know? 🌍 Today is International #ClinicalTrials Day. #EWGPWD & #EDCWG members share why clinical research matters. 🔬 Learn more about Clinical Trials Watch: www.alzheimer-europe.org/research/cli... 🧠 Read about: www.alzheimer-europe.org/resources/pu... #Research #Brainhealth #ICTD
Blood-based biomarkers are rapidly transforming the future of neurodegenerative disease detection - not only for Alzheimer’s disease, but across the wider dementia landscape.
Blood-based biomarkers that test for #Alzheimer’s disease appear acceptable to people in the primary care setting, however some characteristics influence the level of acceptability and potential response to a positive result. #AEScienceWatch www.alzheimer-europe.org/news/survey-...
💡 As part of our partner introduction series, we’re excited to feature the Università degli Studi di Verona. ➡️ In PREDICTFTD the University of Verona contributes to early biomarker validation studies in olfactory mucosa samples using nasal swabs. 🖇️ Find more: lnkd.in/dgaFakjA
@uniuef.bsky.social University of Eastern Finland is a research university located in Finland, with strong focus in neurodegenerative diseases research. 🌟 In PREDICTFTD project, UEF leads prospective data and sample collection and contributes to providing samples, data and local expertise. 🧠
PREDICTFTD coordinator Prof. Harro Seelaar from erasmusmc.bsky.social participated in the latest Alzheimer Europe Academy session, “Not all dementias are Alzheimer’s disease”. During the workshop, Prof. Harro shared a clinician’s perspective on frontotemporal dementia (FTD).
Erasmus MC (@erasmusmc.bsky.social)
Het Erasmus MC in Rotterdam, erkend leidend in innovaties voor gezondheid en zorg. Volg onze verhalen en tag #erasmusmc om jouw verhaal te delen.
erasmusmc.bsky.social
Yesterday, we hosted a session of our popular online series, the "Alzheimer’s Association Academy" #AlzAcademy, entitled "Not all dementias are Alzheimer’s disease”. Read all about it: www.alzheimer-europe.org/news/alzheim...
Blood-based biomarkers are rapidly transforming the future of neurodegenerative disease detection - not only for Alzheimer’s disease, but across the wider dementia landscape.
Blood-based biomarkers that test for #Alzheimer’s disease appear acceptable to people in the primary care setting, however some characteristics influence the level of acceptability and potential response to a positive result. #AEScienceWatch www.alzheimer-europe.org/news/survey-...
Members of the @predictftd.bsky.social Public Involvement Board recently held two meetings with the Office of Health Economics to discuss the value of a faster and more accurate Frontotemporal dementia diagnosis. #PublicInvolvement #FrontotemporalDementia www.alzheimer-europe.org/news/members...
Members of the PREDICTFTD Public Involvement Board meet with the Office of Health Economics to discuss the value of a faster and more accurate Frontotemporal dementia diagnosis
On 26 February and 3 March, the members of the PREDICTFTD Public Involvement Board (PREDICTFTD-PIB) gathered online with Matthias Hofer, Henry Fong an
alzheimer-europe.org
The PREDICTFTD project @predictftd.bsky.social recently held its general assembly meeting in Desenzano del Garda (Italy). Read all about the meeting: www.alzheimer-europe.org/news/predict...
This World Health Day, we bring attention to one of the biggest challenges in neurodegenerative diseases: late and uncertain diagnosis. 🧠 PREDICTFTD aims to transform FTD diagnosis by overcoming the current 3.6-year diagnostic delay! #WorldHealthDay #FTD #Biomarkers #EUProjects
Day 2 of the PREDICTFTD project meeting in Desenzano del Garda. 🌍 A focused day covering biomarker work, AI modelling, and an overview of the olfactory (nasal) swab sampling. We also had important discussions on the regulatory roadmap and ethics - important pieces as the project moves forward.
Day 1 of the PREDICTFTD consortium meeting in Desenzano del Garda! We kicked off with updates across the project, from ongoing work packages to a really interesting demo of how our data systems are coming together. More tomorrow.🚀 #PREDICTFTD
In light of Brain Awareness Week, we are preparing for our upcoming team meeting. 🌍 The PREDICTFTD partners will meet in person on March 26–27, 2026, in Desenzano del Garda, Italy. Looking forward to two productive days of discussion and exchange. 🧠
This Brain Awareness Week, we’re spotlighting the fight against FTD. 🧠 Our goal is vital: to give clinicians the tools they need to diagnose FTD faster, enabling earlier intervention and better care. Learn more about our approach: www.predictftd.eu
The recent @alzheimereurope.bsky.social Europe data on dementia prevalence across Europe is a strong reminder of the growing impact of neurodegenerative diseases! www.alzheimer-europe.org/dementia/pre...
Prevalence of dementia in Europe
alzheimer-europe.org
During #BrainAwarenessWeek, we'd also like to share our new "Prevalence of Dementia in Europe 2025" report. The results show that policy and advocacy are more important than ever. 🧠Where does your country stand? bit.ly/DementiaPrev... bit.ly/DementiaPrev... #dementiaprevalence #dementiaineurope
People with #dementia and carers are experts in lived experience. This #BrainAwarenessWeek, we recognise that #PublicInvolvement shapes research, policy and awareness. #EWGPWD #EDCWG Learn more about: Technology use: bit.ly/4sSR5Bv Sex, Gender and Sexuality bit.ly/4s9DmpJ (DE) bit.ly/4seWClT (FR)
🔬@Leitat Technological Center, Spain, participate in the assessment of the diagnostic potential of biomarkers for FTD detection in the PREDICTFTD project. LEITAT works on biomarker analysis and validation, leading Biomarkers study using Luminex Technology. ✔️ 🔗 Discover more: leitat.org
🌍Teraglobus is a Lithuanian SME engaged in dissemination, exploitation, stakeholder involvement, and healthcare consulting within EU-funded projects. 🔗 Discover more: www.teraglobus.lt
📣 Our first PREDICTFTD newsletter is out! 👉https://www.predictftd.eu/newsletters Open the link to read the newsletter and learn more about what we’re working on.
As part of our partner introduction series, we’re excited to feature Alzheimer Europe. 🤝 In the PREDICTFTD project, @alzheimereurope.bsky.social plays a central role in involving people affected by FTD, raising awareness, engaging stakeholders, and building a dialogue with EU policymakers.